1-3 of 3
Paul A. Algate, PhD
Close
Sort by
Journal Articles

Bispecific SCORPION™ Molecules Effectively Redirect T-Cell Cytotoxicity Toward CD19-Expressing Tumor Cells

Ruth A. Chenault, Rebecca Gottschalk, Gabriela Hernandez-Hoyos, PhD, Jennifer Wiens, Brian Gordon, Jennifer Klee, Jessica Bienvenue, Maria Dasovich, John Kumer, Megan Aguilar, Jeannette Bannink, Catherine J. McMahan, PhD, Sateesh Natarajan, PhD, Paul A. Algate, PhD, John W. Blankenship, PhD
Journal: Blood
Blood (2012) 120 (21): 3722.
https://doi.org/10.1182/blood.V120.21.3722.3722
Published: 2012
Journal Articles

Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals

Rosa Lapalombella, PhD, Asha Ramanunni, MD, Yuh-Ying Yeh, PhD, Liwen Wang, PhD, Shruti Jha, Justin Staubli, Sarah E. M. Herman, PhD, Leslie A Andritsos, MD, Jeffrey A. Jones, MD, MPH, Joseph M. Flynn, DO, MPH, Xiaokui Mo, PhD, MAS, Amy J. Johnson, PhD, Peter Thompson, MD, Paul A. Algate, PhD, Scott Stromatt, MD, Michael A Freitas, Ph.D., Natarajan Muthusamy, DVM, Ph.D, John C. Byrd, MD
Journal: Blood
Blood (2011) 118 (21): 622.
https://doi.org/10.1182/blood.V118.21.622.622
Published: 2011
Journal Articles

TRU-016, An Anti-CD37 SMIP™ Biologic, In Combination with Other Therapeutic Drugs In Models of Non-Hodgkin's Lymphoma

Paul A. Algate, PhD, Jennifer Wiens, Christy Nilsson, Mien Sho, Debra T. Chao, PhD, Gary C. Starling, PhD, John C. Byrd, MD, Brian Gordon
Journal: Blood
Blood (2010) 116 (21): 3931.
https://doi.org/10.1182/blood.V116.21.3931.3931
Published: 2010